Zhang et al., 2010 - Google Patents
Association of human μ‐opioid receptor gene polymorphism A118G with fentanyl analgesia consumption in Chinese gynaecological patientsZhang et al., 2010
View PDF- Document ID
- 8191635395412858198
- Author
- Zhang W
- Chang Y
- Kan Q
- Zhang L
- Lu H
- Chu Q
- Wang Z
- Li Z
- Zhang J
- Publication year
- Publication venue
- Anaesthesia
External Links
Snippet
One hundred and seventy‐four Chinese gynaecology patients were studied for the impact of A118G polymorphism in the μ‐opioid receptor gene (OPRM1) on pain sensitivity and postoperative fentanyl consumption. Pre‐operatively, the pain threshold and pain tolerance …
- 229960002428 Fentanyl 0 title abstract description 47
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Association of human μ‐opioid receptor gene polymorphism A118G with fentanyl analgesia consumption in Chinese gynaecological patients | |
Chou et al. | Association of μ‐opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty | |
Tan et al. | Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain | |
Wong et al. | Observational study of the effect of μ-opioid receptor genetic polymorphism on intrathecal opioid labor analgesia and post-cesarean delivery analgesia | |
Mura et al. | Consequences of the 118A> G polymorphism in the OPRM1 gene: translation from bench to bedside? | |
Kolesnikov et al. | Combined catechol-O-methyltransferase and μ-opioid receptor gene polymorphisms affect morphine postoperative analgesia and central side effects | |
Park et al. | Genetic polymorphisms in the ABCB1 gene and the effects of fentanyl in Koreans | |
Janicki et al. | A genetic association study of the functional A118G polymorphism of the human μ-opioid receptor gene in patients with acute and chronic pain | |
J Mistry et al. | Genetics of opioid dependence: a review of the genetic contribution to opioid dependence | |
Kim et al. | Genetic polymorphisms in monoamine neurotransmitter systems show only weak association with acute post-surgical pain in humans | |
Kaye et al. | Update on the pharmacogenomics of pain management | |
Kosek et al. | Genetic variation in the serotonin transporter gene (5-HTTLPR, rs25531) influences the analgesic response to the short acting opioid Remifentanil in humans | |
Khalil et al. | OPRM1 and COMT gene–gene interaction is associated with postoperative pain and opioid consumption after orthopedic trauma | |
Kolesnikov et al. | Chronic pain after lower abdominal surgery: do catechol-o-methyl transferase/opioid receptor μ− 1 polymorphisms contribute? | |
Clarke et al. | Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females | |
Dong et al. | Effect of CYP3A4* 1G on the fentanyl consumption for intravenous patient‐controlled analgesia after total abdominal hysterectomy in Chinese Han population | |
Compton et al. | Association between human μ‐opioid receptor gene polymorphism, pain tolerance, and opioid addiction | |
Liao et al. | Effect of CYP3A4* 18B polymorphisms and interactions with OPRM1 A118G on postoperative fentanyl requirements in patients undergoing radical gastrectomy | |
TSAI et al. | Human opioid μ‐receptor A118G polymorphism may protect against central pruritus by epidural morphine for post‐cesarean analgesia | |
Camorcia et al. | Effect of μ-opioid receptor A118G polymorphism on the ED50 of epidural sufentanil for labor analgesia | |
Robles et al. | Pain and genetics | |
Song et al. | Effects of OPRM1 A118G polymorphism on epidural analgesia with fentanyl during labor: a meta-analysis | |
Zhao et al. | Effects of OPRM1 and ABCB1 gene polymorphisms on the analgesic effect and dose of sufentanil after thoracoscopic-assisted radical resection of lung cancer | |
Landau et al. | Genetic variability of μ-opioid receptor in an obstetric population | |
Sugino et al. | Association of μ-opioid receptor gene (OPRM1) haplotypes with postoperative nausea and vomiting |